Surgery – Blood drawn and replaced or treated and returned to body
Reexamination Certificate
2005-08-02
2005-08-02
Bianco, Patricia (Department: 3762)
Surgery
Blood drawn and replaced or treated and returned to body
C210S739000, C210S143000, C210S646000, C210S650000, C706S924000
Reexamination Certificate
active
06923782
ABSTRACT:
A graphical user interface for a medical instruments for a Renal Replacement Therapy includes a pictogram representation of cthe fluid path of an extracorporeal blood circuit that represents fluid lines, pumps and sensors. To assist the user in responding to alarms and rectifying faults in the system the source of a potential trouble is animated. The location of a trouble spot is easily identified by flashing of the corresponding element of the pictogram, change of color or thickness of a corresponding line.
REFERENCES:
patent: 4086924 (1978-05-01), Latham, Jr.
patent: 4599055 (1986-07-01), Dykstra
patent: 4657529 (1987-04-01), Prince et al.
patent: 4824339 (1989-04-01), Bainbridge et al.
patent: 4936980 (1990-06-01), Yoshimichi et al.
patent: 5114580 (1992-05-01), Ahmad et al.
patent: 5312550 (1994-05-01), Hester
patent: 5366630 (1994-11-01), Chevallet
patent: 5487827 (1996-01-01), Peterson et al.
patent: 5536237 (1996-07-01), Prince et al.
patent: 5609770 (1997-03-01), Zimmerman et al.
patent: 5653887 (1997-08-01), Wahl et al.
patent: 5685989 (1997-11-01), Krivitski et al.
patent: 5707086 (1998-01-01), Treu et al.
patent: 5725776 (1998-03-01), Kenley et al.
patent: 5730712 (1998-03-01), Falkvall et al.
patent: 5762805 (1998-06-01), Truitt et al.
patent: 5776345 (1998-07-01), Truitt et al.
patent: 5788851 (1998-08-01), Kenley et al.
patent: 5906589 (1999-05-01), Gordon et al.
patent: 5910252 (1999-06-01), Truitt et al.
patent: 6090048 (2000-07-01), Hertz et al.
patent: 6146523 (2000-11-01), Kenley et al.
patent: 6538672 (2003-03-01), Dobbelaar
patent: 6560492 (2003-05-01), Borders
patent: 2001/0016699 (2001-08-01), Burbank et al.
patent: 2001/0021817 (2001-09-01), Brugger et al.
patent: 2001/0037079 (2001-11-01), Burbank et al.
patent: 2001/0041892 (2001-11-01), Burbank et al.
patent: 2002/0103453 (2002-08-01), Burbank et al.
patent: 2002/0147423 (2002-10-01), Burbank et al.
patent: 2003/0009123 (2003-01-01), Brugger et al.
patent: 2003/0097087 (2003-05-01), Gura
patent: 0 274 178 (1988-07-01), None
patent: 0 990 444 (2000-04-01), None
patent: 1 583 023 (1981-01-01), None
International Search Report dated Sep. 11, 2002.
Jonathan D. Sackner-Bernstein, MD et al., “How Should Diuretic-Refractory, Volume-Overloaded Heart Failure Patients Be Managed?” The Journal of Invasive Cardiology, vol. 15, No. 10 (Oct. 2003), pp. 585-590.
Brian E. Jaski, MD et al., “Peripherally Inserted Veno-Venous Ultrafiltration for Rapid Treatment of Volume Overloaded Patients”, Journal of Cardiac Failure, vol. 9, No. 3, (Jun. 2003), pp. 227-231.
Strife, C.F. et al, “Experience With a Low Volume Ultrafiltration Cell in Small Children,” Clinical Nephrology 8:410-413 (1977).
Lauer, A. et al, “Continuous Arteriovenous Hemofiltration in the Critically Ill Patient, Clinical Use and Operational Characteristics,” Annals of Internal Medicine 99:455-460 (1983).
Verbanck, J. et al, “Pure Ultrafiltration by Repeated Puncture of a Peripheral Arm-Vein as Treatment of Refractory Edema”, The International Journal of Artificial Organs, vol. 3, No. 6 (1980), pp 342-343.
Silverstein et al, “Treatment of Severe Fluid Overload by Ultrafiltration,” The New England Journal of Medicine, vol. 291, No. 15, Oct. 10, 1974, pp. 747-751.
Blake, P. et al, “Refractory Congestive Heart Failure: Overview and Application of Extracorporeal Ultrafiltration,” Critical Care Nephrology,Advances in Renal Replacement Therapy, vol. 3, No. 2 (Apr. 1966), pp. 166-173.
Civati G. et al, “Haemofiltration Without Substitution Fluid,” Proc. EDTA-ERA, vol. 21 (1984), pp. 441-446.
Jenkins, R.D. et al, “The Use of Continuous Arteriovenous Hemofiltration With Hemodialysis in a Newborn,” Draft #6, Personal Communication, 1985 (6 pages).
Jacobs, C. et al, “Continuous Arteriovenous Hemofiltration,” Replacement of Renal Function By Dialysis, 4thEd., (1996) pp. 391-397.
Gupta, B.B. et al, “High Shear Rate Hemofiltration: Influence of Fiber Dimensions and Shear Rates,” Artificial Organs, International Society for Artificial Organs, vol. 13(2) (1989), pp. 97-102.
Rimondini, A. et al, “Hemofiltration as Short-Term Treatment for Refractory Congestive Heart Failure,” The American Journal of Medicine, vol. 83, Jul. 1987, pp 43-48.
Donato, L. et al, “Treatment of End-Stage Congestive Heart Failure by Extracorporeal Ultrafiltration,” The American Journal of Caridology, vol. 59, (Feb. 1, 1987), pp. 379 and 380.
L'Abbate, A. et al, “Ultrafiltration: A Rational Treatment for Heart Failure,” Cardiology 1989; 76:384-390.
Chen, Y. et al, “Direct Peripheral Venopuncture: Another New Choice of Temporary Vascular Access”, Renal Failure, 22(3), 369-377 (2000).
PRISMA, M60 Set, Instructions for Use.
Gelfand Mark
Halpert Andrew
O'Mahony John J.
Bianco Patricia
CHF Solutions Inc.
Nixon & Vanderhye P.C.
LandOfFree
User interface for blood treatment device does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with User interface for blood treatment device, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and User interface for blood treatment device will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3445130